Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-04-26
2011-04-26
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
07932226
ABSTRACT:
It is intended to surely and effectively inhibit the transcriptional activity of NFκB and to obtain a more effective anti-inflammatory effect. Further, it is intended to obtain an equivalent effect even if the amount used of a steroid agent is reduced.An agent is characterized by containing MTI-II, especially a nucleic acid sequence of SEQ ID NO: 1, or a peptide of SEQ ID NO: 2. This MTI-II peptide is preferably a peptide containing at least an acidic amino acid domain (SEQ ID NO: 3). Further, a steroid agent such as triamcinolone acetonide is used concomitantly with MTI-II, especially the nucleic acid sequence of SEQ ID NO: 1 or the peptide of SEQ ID NO: 2.
REFERENCES:
patent: 6780970 (2004-08-01), Bonny
patent: 2004/0002521 (2004-01-01), Iino et al.
patent: 8-319238 (1996-12-01), None
patent: 9-59151 (1997-03-01), None
patent: 11-279057 (1999-10-01), None
patent: 2000-224993 (2000-08-01), None
patent: 2003-511071 (2003-03-01), None
patent: WO 02/26547 (2002-05-01), None
patent: WO 02/36547 (2002-05-01), None
patent: WO 03/016475 (2003-02-01), None
patent: WO 03/072035 (2003-09-01), None
Okamoto, et al., “The new type coactivator (MTI-ii) colocalizes with gulucocorticoid-receptor and enhances transcription through its acidic domain in vivo,”Seikagaku, vo. 76, No. 8, p. 1046, Aug. 25, 2004.
Okamoto, et al., “The nuclear acidic protein (MTI-II is a new type of nuclear-receptor coactivator,”Vitamins, vol. 78, No. 4, p. 283, 2004.
Scheinman, et al., “Characterization of Mechanisms Involved in Transrepression of KF-fB by activated Glucocoriticoid Receptors,”Molecular and Cellular Biology, Vo. 15, No. 2, p. 943-953, 1995.
International Search Report in PCT/JP2005/011851 dated Aug. 9, 2005.
Almawi et al., “Negative Regulation of Nuclear Factor-κB Activation and Function by Glucocorticoids,”J. Mol. Endo., 28(2):69-78 (2002).
D'Acquisto et al., “Inhibition of Nuclear Factor Kappa B (NF-κB): An Emerging Theme in Anti-Inflammatory Therapies,”Mol. Interv., 2(1):22-35 (2002).
Hannappel et al., “The Thymosins. Prothymosin α, Parathymosin, and β-Thymosins: Structure and Function,”Vitamins and Hormones, 66:257-296 (2003).
Leondiadis et al., “Synthesis, Mass Spectrometry Analysis and Potency of an Parathymosin (101 Amino Acids),”J. Peptide Sci., 8(Supp.):S118 (2002).
Okamoto et al., “Macromolecular Translocation Inhibitor II (Zn2+-Binding Protein, Parathymosin) Interacts with the Glucocorticoid Receptor and Enhances Transcription in Vivo,”J. Biol. Chem., 280(44):36986-36993 (2005).
Okamoto et al., “Purification and Primary Structure of a Macromolecular-Translocation Inhibitor II of Glucocorticoid-Receptor Binding to Nuclei from Rat Liver Inhibitor II is the 1 1.5-kDa Zn2+-Binding Protein (Parathymosin),”Eur. J. Biochem/FEBS, 267(1):155-162 (2000).
Salvin et al., “Potential Regulation of Immunity by the Peptides Prothymosin α and Parathymosin,”Lymphokine Res., 6(1):1437 (1987).
Salvin et al., “Regulation of Immune Responses by the Thymic Peptides, Prothymosin-α and Parathymosin-α1,”Natural Immunity and Cell Growth Regulation, 4(5):275 (1985).
Supplementary European Search Report for Application No. 05 75 5776, dated Aug. 24, 2009.
Okamoto, et al., “The nuclear acidic protein (MTI-II is a new type of nuclear-receptor coactivator,”Vitamins, vol. 78, No. 4, p. 263, 2004.
Isohashi Fumihide
Okamoto Kazuki
Li Ruixiang
Marshall & Gerstein & Borun LLP
St. Marianna University School of Medicine
LandOfFree
NFκB transcriptional activity inhibitory agent and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NFκB transcriptional activity inhibitory agent and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NFκB transcriptional activity inhibitory agent and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665710